Use of 5α-reductase inhibitors and survival of oesophageal and gastric cancer in a nationwide Swedish cohort study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Use of 5α-reductase inhibitors and survival of oesophageal and gastric cancer in a nationwide Swedish cohort study

Published:2023-05-04 Issue:5 Volume:62 Page:438-443
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Rabbani Sirus¹,Mattsson Fredrik¹,Lagergren Jesper¹²,Xie Shaohua¹³

Affiliation:

1. Upper Gastrointestinal Surgery, Department of Molecular medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

2. School of Cancer and Pharmaceutical Sciences, King’s College London, United Kingdom

3. School of Public Health and Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, P.R. China

Funder

Swedish Cancer Society

Swedish Research Council

Publisher

Medical Journals Sweden AB

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2023.2214681

Reference54 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. SEER cancer statistics review, 1975-2016 [internet]. Bethesda, MD: National Cancer Institute. 2018. [cited November 2022]. Available from: https://seer.cancer.gov/csr/1975_2016/.

3. Gastric cancer: epidemiology, prevention, classification, and treatment

4. Life Expectancy in Survivors of Esophageal Cancer Compared with the Background Population

5. The Male Predominance in Esophageal Adenocarcinoma

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP